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Abstract
Background: Susceptibility to Bordetella pertussis infection varies widely. These differences can partly be explained by
genetic host factors. HcB-28 mice are more resistant to B. pertussis infection than C3H mice, which could partially be
ascribed to the B. pertussis susceptibility locus-1 (Bps1) on chromosome 12. The presence of C57BL/10 genome on this
locus instead of C3H genome resulted in a decreased number of bacteria in the lung. To further elucidate the role of
host genetic factors, in particular in the Bps1 locus, in B. pertussis infection, and to identify candidate genes within in this
region, we compared expression profiles in the lungs of the C3H and HcB-28 mouse strains following B. pertussis
inoculation. Twelve and a half percent of the genomes of these mice are from a different genetic background.
Results: Upon B. pertussis inoculation 2,353 genes were differentially expressed in the lungs of both mouse strains. Two
hundred and six genes were differentially expressed between the two mouse strains, but, remarkably, none of these were
up- or down-regulated upon B. pertussis infection. Of these 206 genes, 17 were located in the Bps1 region. Eight of these
genes, which showed a strong difference in gene expression between the two mouse strains, map to the immunoglobulin
heavy chain complex (Igh).
Conclusion: Gene expression changes upon B. pertussis infection are highly identical between the two mouse strains
despite the differences in the course of B. pertussis infection. Because the genes that were differentially regulated between
the mouse strains only showed differences in expression before infection, it appears likely that such intrinsic differences
in gene regulation are involved in determining differences in susceptibility to B. pertussis infection. Alternatively, such
genetic differences in susceptibility may be explained by genes that are not differentially regulated between these two
mouse strains. Genes in the Igh  complex, among which Igh-1a/b, are likely candidates to explain differences in
susceptibility to B. pertussis. Thus, by microarray analysis we significantly reduced the number of candidate susceptibility
genes within the Bps1 locus. Further work should establish the role of the Igh complex in B. pertussis infection.
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Background
Bordetella pertussis is a gram-negative bacterium that can
cause the respiratory disease known as pertussis or
whooping cough in humans. Susceptibility to this disease
and its course vary widely between individuals [1]. We
have previously shown that genetically divergent mouse
strains differ in their response to B. pertussis infection,
underlining that infection is influenced by host genetic
factors[2,3]. In addition, a role of several host genetic loci
in the course of B. pertussis infection has been indicated,
such as the toll-like receptor 4 (Tlr4) gene [2-5], the inter-
feron gamma receptor gene [6], and three novel loci, B.
pertussis susceptibility locus 1, 2, and 3 (Bps1, 2, and 3) [2]
that showed linkage with the severity of infection.
We have used recombinant congenic mouse strains (RCS)
as a tool to facilitate the mapping of low-penetrance
quantitative trait loci that control complex traits such as a
B. pertussis infection [7]. RCS are derived from two differ-
ent inbred strains, the so-called background and donor
strain. After two backcrosses and subsequent brother-sis-
ter mating, a set of RCS is created, with each strain con-
taining 12.5% of the donor genome differently
distributed across the background genome [8]. HcB/Dem
RCS of mice are derived from two backcrosses of the
inbred mouse strains C3H/DISnA (C3H) as background
and C57BL/10ScSnA (B10) as donor strain, resulting in
12.5% B10 genome across the C3H genome. The genome
of each HcB/Dem strain, thus, differs maximally 12.5%
compared to the background strain (C3H) (Figure 1a)
[9,10]. HcB-28 mice contained lower numbers of bacteria
in their lungs seven days post-inoculation compared to
C3H mice. Subsequent genotyping led to the identifica-
tion of the three susceptibility loci, Bps1, 2, and 3. Espe-
cially Bps1 displayed strong linkage with susceptibility to
B. pertussis infection. The Bps1 locus is located on chromo-
some 12, spanning a region of 185 genes, of which one or
more genes have a dominant positive effect on the clear-
ance of B. pertussis in the lung, and/or the reduction of
bacterial multiplication. However, the mechanism by
which genes within this region influence the course of
infection is not clear. Two other loci, Bps-2  and Bps-3,
showed genetic interaction and are located on chromo-
somes 5 and 11, respectively [2].
Although Bps-1 has not yet been validated, we believe that
the significance of this locus warrants further study. To
further elucidate the role of host genetic factors, in partic-
ular the Bps1 locus, in B. pertussis infection, and to identify
candidate genes within this region, we studied expression
profiles in the lungs of mice following B. pertussis inocula-
tion. The traditional approach for mapping genes in sus-
ceptibility loci is a combination of positional cloning and
linkage analysis [11,12]. Although this strategy has
proven to be effective [7,13], the approach is quite costly
and animal-consuming. Previously we identified changes
in gene expression in the lungs of C3H/DISnA mice after
B. pertussis infection, and we especially focused on differ-
entially expressed genes in the lungs of infected and non-
infected mice located in Bps1,-2, and -3 [14]. We found
that the expression of 1,841 genes was significantly
changed upon B. pertussis infection. These genes are
involved in various immune-related processes, such as the
acute-phase response, antigen presentation, cytokine pro-
Differences between C3H/DISnA and HcB-28/Dem mice Figure 1
Differences between C3H/DISnA and HcB-28/Dem mice. a) Illustration of the distribution pattern of B10 genome 
across the background genome of the C3H strain of the Recombinant Congenic Strain HcB-28/Dem. The HcB-28 strain was 
derived by crossings between mouse strains C3H/DISnA as background (displayed in grey) and C57BL/10 as donor (displayed 
in black). b) Mice (C3H/DISnA) were infected intranasally with B. pertussis strain B213. The lungs were removed seven days 
after inoculation, and the number of viable B. pertussis was determined. Bars represent the average number of bacteria in the 
lungs. Horizontal line indicates the significant difference between groups. Error bars indicate the Standard Deviation (SD).
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duction, inflammation, and apoptosis. Nine of the differ-
entially expressed genes are located in Bps1, 13 are located
in Bps-2, and 62 are located in Bps-3.
In the present study we compared the gene expression
profiles in the lungs of two mouse strains, i.e. HcB-28/
Dem and C3H, which showed a different course of B. per-
tussis infection, in order to further identify candidate sus-
ceptibility genes without the need for positional cloning.
We hypothesized that the phenotypic differences dis-
played by these mice in the response to B. pertussis can
partly be explained by a different gene expression profile
between the mouse strains, and that this approach could
lead to the identification of candidate genes affecting the
course of infection. Using this approach we reduced the
number of candidate susceptibility genes within the Bps1
locus.
Methods
Experimental design
Forty-eight female HcB-28/Dem and 48 female C3H/
DISnA (the background strain of the HcB-28/Dem) mice
were intranasally inoculated with 2*107 colony forming
units (CFU) of the streptomycin-resistant Tohama strain
of B. pertussis (B213) in 40 µl Verwey medium (The Neth-
erlands Vaccine Institute, Bilthoven, the Netherlands), or
as a control with Verwey Medium only (total of 96 mice).
One, three, and five days after inoculation, 8 infected and
8 control mice were euthanized. To remove blood from
the lungs, mice were perfused with phosphate-buffered
saline (PBS, Tritium Microbiology, Veldhoven, the Neth-
erlands). Subsequently, the lungs and trachea were col-
lected [15,16]. For RNA extraction, the right lung was
collected in RNA stabilization reagent (RNAlater, Qiagen,
Venlo, the Netherlands). For histological examination,
the left lung was fixed intratracheally using 4% formalin.
The number of viable B. pertussis bacteria was determined
in the trachea to confirm a proper infection [17] (Note
that tracheal counts are not representative for bacterial
clearance from the lungs.) To this end, approximately one
centimeter of the trachea was collected in 500 µl Verwey
medium. Bacterial suspensions were diluted in Verwey
medium and the number of CFU was determined by plat-
ing on Bordet Gengou agar supplemented with 15%
sheep blood and 30 µg/ml streptomycin (Tritium Micro-
biology). Plates were incubated for 4 days at 35°C and the
resulting colonies were counted using a ProtoCOL Colony
counter (Synbiosis, Cambridge, United Kingdom).
All B. pertussis-infected mice had between 102 and 105 CFU
in the trachea during the first five days after inoculation,
confirming an actual infection (data not shown).
For the analysis of intrinsic immunological and cellular
differences between the two mouse strains, independent
from infection, blood and spleen samples were collected
from five untreated female mice of both strains.
Animals
Breeding pairs of C3H/DISnA and HcB-28/Dem were sup-
plied by the Department of Molecular and Cellular Biol-
ogy, Roswell Park Cancer Institute, Buffalo, New York.
Female mice were bred to the appropriate numbers at our
animal testing facility in Bilthoven, the Netherlands. Mice
were acclimatized for at least one week before the start of
the experiments. Mice received standard laboratory food
(SRM-A, Hope Farms, Woerden, the Netherlands) and tap
water ad libitum. All animal experiments were approved
by the Institute's Animal Ethics Committee and were per-
formed according to NIH guidelines [18] and Dutch legis-
lation.
Clinical and pathological examinations
Mice were weighed before inoculation, and subsequently
every day after inoculation to determine the relative
change in weight. Lung weights were determined post
mortem as quantitative parameter for lung inflammation.
Formalin-fixed lungs were embedded in paraplast
(Monoject Inc., St Louis, MO). Sections (5 µm) were
stained with hematoxylin-eosin. Lung lesions were exam-
ined for infiltration of inflammatory cells in the peribron-
chiolar space (peribronchiolitis), infiltration of
inflammatory cells in the alveoli (alveolitis), infiltration
of inflammatory cells in the perivascular space (perivascu-
litis), hypertrophy of mucus-producing glands, free pro-
tein (exudate), and eosinophilia. Lung lesions were scored
semi-quantitatively as absent, minimal, slight, moderate,
marked, or strong, as previously described [19].
Enumeration of cellular subsets
Spleens were harvested and weighed. Cell suspensions
were prepared and the number of nucleated cells per
spleen was determined using a Coulter Counter Z2 (Beck-
man Coulter, Mijdrecht, the Netherlands). The percentage
of B- and T-cells, as well as T-cell subsets were determined
using a fluorescence-activated cell sorter (FACS-Calibur,
BD Biosciences, Alphen aan den Rijn, the Netherlands). T-
cells were detected with phycoerythrin-labeled (PE) anti-
CD3ε antibodies (Molecular probes, Invitrogen, Breda,
the Netherlands). CD4+ T-cells were determined using
allophycocyanin-labeled (APC) antibodies (Molecular
probes) and CD8+T-cells were determined using fluores-
cein isothiocyanate-labeled (FITC) antibodies (Molecular
probes). B-cells were determined using PE-labeled anti-
CD19 antibodies (Molecular probes).BMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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Splenocyte proliferation test
The cell suspensions were used to measure the spontane-
ous (medium only) or stimulus-induced 3H-thymidine
uptake. The cells were stimulated by adding 10 µg/ml
Concavalin A (Con A, T-cell stimulus), 70 µg/ml lipopol-
ysacharide (LPS, B-cell stimulus) or 15 µg/ml Lectin (B-
and T-cell stimulus) to the culture medium. Cells were
incubated for 72 hr at 37°C. 3H-thymidine was present
during the final 24 hr of culture. See [20] for details.
Hematology
The morphologic hemogram was determined using an
ADVIA 120 Hematology system (Multispecies analyzer,
Bayer, Mijdrecht, the Netherlands).
Immunoglobulin quantification
Blood was collected in Vacuette Minicollect tubes
(Greiner bio-one, Alphen a/d Rijn, the Netherlands), and
serum was removed by centrifugation. Immunoglobulins
were determined using the multiplex Beadlyte Mouse
Immunoglobulin Isotyping Kit (Millipore, Billerica, MA)
for the Luminex platform (Luminex, Oosterhoud, the
Netherlands), as prescribed by the manufacturer.
Transcription profiling
Microarray analysis experiments were performed as
described previously [14]. Briefly, total RNA was extracted
from lungs and amplified using the Amino Allyl Mes-
sageAmp II aRNA kit (Ambion Inc., Austin, TX). RNA
amplification was performed to obtain more nucleic acid
for labeling. This results in a stronger fluorescence signal
and a better signal/noise ratio. Because of this, less exper-
imental samples (and therefore animals) are needed to
obtain sufficient statistical power. RNA samples from
individual mice were labeled with Cy3. A common refer-
ence containing a RNA pool of all samples isolated was
labeled with Cy5.
Microarray slides were spotted at the Microarray Depart-
ment of the University of Amsterdam. The slides contain
21,997 65-mer oligonucleotides from the Sigma-Compu-
gen Mouse oligonucleotide library, 192 additional 65-
mer oligonucleotides of genes of which 185 are located in
the Bps1 region spotted in duplicate (Isogen Life science,
IJsselstein, the Netherlands), as well as appropriate con-
trols and blank spots. The Bps-1 oligonucleotides were
annotated according to NCBI mouse genome build 34.1;
all other oligonucleotides were annotated according to
the Sigma-Compugen Mouse oligonucleotide library.
At least 5 slides per group were used. Raw microarray sig-
nal data were normalized and analyzed in the R statistical
software environment [21-23]. Significance of differences
in gene expression between the experimental groups was
calculated in R with ANOVA. The false discovery rate
(FDR) was calculated according to Benjamini and Hoch-
berg [24]. Gene expression data were visualized by hierar-
chical clustering (using Euclidian distance and Ward
linkage) using GeneMaths (Applied Maths, St-Martens-
Latem, Belgium). Gene categories were defined by Gene
Ontology (GO) [25], Classification and enrichment
according to GO categories or location were determined
using DAVID/EASE [26,27], using EASE-scores as P-value
for enrichment.
Results
Response of C3H and HcB mice to infection
We have previously examined clearance of B. pertussis
from the lungs of infected RCS mice, and established that
HcB-28 mice contained lower numbers of bacteria in their
lungs seven days post inoculation compared to C3H mice
(Figure 1b) [2]. To examine whether the genetic differ-
ences between "resistant" HcB-28 mice and "susceptible"
C3H mice also result in a different transcriptional
response to B. pertussis infection, we compared gene
expression profiles of the lungs of infected and uninfected
HcB-28 and C3H mice [2,14]. mRNA transcription pro-
files were determined in at least five animals per group.
The three mock-inoculated groups of each mouse strain,
euthanized at days one, three and five, were found to be
statistically indistinguishable from each other, i.e. both
within the same strain and between strains (i.e. there were
no genes with FDR < 0.6). Of the approximately 22k genes
tested, 2,559 genes were significantly differentially
expressed either in the two mouse strains or upon B. per-
tussis-inoculation (FDR <0.05, corresponding to P <
0.0058). The gene expression levels of all 2,559 genes are
presented in additional file 1. The expression profiles of
all genes are illustrated by hierarchical clustering in Figure
2. ANOVA analysis identified 206 genes (groups A and B)
that were differentially expressed between the two mouse
strains before inoculation, and 2,353 genes (groups C and
D) that were differentially expressed in both strains after
infection. Remarkably, there were no genes that were dif-
ferentially expressed between the two mouse strains fol-
lowing inoculation. Thus, genes up- or down-regulated
upon infection were identically regulated in both mouse
strains despite their clear genetic differences and differ-
ences in B. pertussis susceptibility.
The 206 genes that were differentially expressed between
the two strains were all unaffected by infection, but dis-
played a difference in basal expression level. Of the 206
strain-dependent genes, 107 genes were expressed at a
higher level in C3H/DISnA mice (group A) and 99 genes
were expressed at a higher level in the HcB-28/Dem mice
(group B). Of the 2,353 infection-regulated genes, 963
were down-regulated upon infection (group C), and
1,390 were up-regulated upon infection (group D). AllBMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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Presentation of microarray data from mock-and B. pertussis- inoculated mice Figure 2
Presentation of microarray data from mock-and B. pertussis- inoculated mice. Analysis was performed on 2,559 
genes whose expression was found to be significantly up- or down-regulated at an FDR < 0.05. Relatively increased gene-
expression is presented in red while relatively decreased gene-expression is presented in green. The color scale shows log(2) 
ratios of gene-expression levels compared to the global average. ANOVA analysis identified 206 genes that were differentially 
expressed between the two mouse strains and 2,353 genes that were differentially expressed after infection. Hierarchical clus-
tering of the 2,559 regulated genes results in four distinct groups, higher in C3H (A), higher in HcB-28 (B), down-regulated 
after infection in both strains (C) and up-regulated after infection in both strains (D).
mock     infection       mock      infection
Day   1    3    5    1    3    5    1    3    5    1    3    5
3
0
-3
C3H/DISnA                 HcB28/Dem
Group A: 107 genes
Group B: 99 genes
Group C: 963 genes
Group D: 1,390 genesBMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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genes that were affected by B. pertussis infection followed
a similar trend in time. One day post-inoculation differen-
tial gene expression was already observed, but the effect
was stronger on days three and five post-inoculation. Thus
there was no identifiable subset of genes that displayed a
different kinetic trend in gene expression.
To assign functions to the differentially expressed genes,
we classified them according to Gene Ontology (GO) cat-
egories. In addition, we determined enrichment for loca-
tion and biological functions to identify
pathophysiological processes involved in the response to
B. pertussis inoculation. The most important GO catego-
ries, i.e. with the highest percentage differentially
expressed genes, are summarized in Table 1. Many genes
that were differentially regulated between the two strains
of mice (groups A and B) are located on chromosome 12,
predominantly in Bps1 (8 in group A and 9 in group B)[2].
All the 17 genes that were differentially expressed in the
mouse strains C3H and HcB-28 and that are located in
Bps1 are presented in Table 2, and may be considered as
candidate susceptibility genes. Of these genes, the strong-
est differences in gene expression between the mouse
strains were found for a cDNA sequence in group A
(BC022687, up to 3.7-fold higher in C3H mice) and for
Immunoglobulin heavy chain 1 in group B (Igh-1, up to
3.6-fold higher expression in HcB-28 mice). Eight genes
within Bps1 (6 in group A and 2 in group B) showed a
strong difference (i.e. at least two-fold) in gene expression
between the two mouse strains, and map to the immu-
noglobulin heavy chain complex (Igh).
Of the 2,353 genes that were differentially expressed after
B. pertussis infection, 1,702 genes were identical to the
genes we have described previously to be regulated upon
B. pertussis infection [14]. Thus by examining additional
mice, we identified approximately 650 additional genes
regulated by B. pertussis, most of which were weakly up- or
down-regulated. Most up-regulated genes upon B. pertus-
sis  infection (group D) are involved in immune- and
inflammation-related processes or in generic processes,
while most down-regulated genes (group C) are involved
in non-immune processes such as muscle contraction.
Hematologic and immunologic analyses in non-infected 
C3H and HcB-28 mice
To investigate possible differences in the basal immuno-
logical parameters between the two strains, we analyzed
hematologic parameters, mitogen-induced splenocyte
proliferation, and lymphocyte subset distributions.
Because the two mouse strains displayed clear differences
in basal gene expression, we wanted to examine if these
differences led to alterations in blood cell composition or
basal immune status. We observed a slightly higher
number of platelets (P = 0.0003) in the C3H/DISnA mice
(1.1*1012/l) compared to the HcB-28/Dem mice
(9.6*1011/l), and a slightly higher number of white blood
cells (P = 0.006) in the C3H/DISnA mice (7.3*109/l) com-
pared to the HcB-28/Dem mice (6.5*109/l), but no differ-
ences in the numbers of red blood cells, reticulocytes,
lymphocytes, neutrophils, eosinophils, and basophils
(data not shown).
Table 1: Gene-ontology based classification of genes with different expression
Group A Group B Genotype (A+B) Group C Group D Infection (C+D) Total on array
Acute-phase response 0 (0%) 0 (0%) 0 (0%) 0 (0%) 13 (59%) 13 (59%) 22
Antigen presentation 0 (0%) 0 (0%) 0 (0%) 0 (0%) 23 (72%) 23 (72%) 32
Apoptosis 0 (0%) 3 (1%) 3 (1%) 9 (3%) 50 (15%) 59 (18%) 324
Cell cycle 0 (0%) 1 (0%) 1 (0%) 30 (6%) 59 (12%) 89 (17%) 510
Chemokine Activity 0 (0%) 0 (0%) 0 (0%) 1 (3%) 24 (67%) 25 (69%) 36
Mus musculus 12a 12 (2%) 11 (2%) 23 (4%) 34 (6%) 38 (7%) 72 (13%) 560
Bps-1 (Mus musculus 12) 8 (4%) 9 (5%) 17 (9%) 6 (3%) 8 (4%) 14 (8%) 185
Complement activation 0 (0%) 1 (3%) 1 (3%) 1 (3%) 8 (26%) 9 (29%) 31
Cytokine Activity 0 (0%) 0 (0%) 0 (0%) 8 (4%) 56 (29%) 64 (33%) 192
Cytoskeleton 0 (0%) 2 (0%) 2 (0%) 48 (9%) 45 (8%) 93 (18%) 531
Development 5 (0%) 9 (1%) 14 (1%) 137 (10%) 118 (8%) 255 (18%) 1433
Immune response 1 (0%) 2 (0%) 3 (1%) 6 (1%) 176 (43%) 182 (45%) 408
Inflammatory response 0 (0%) 1 (1%) 1 (1%) 5 (4%) 52 (43%) 57 (47%) 121
Metabolism 3 (0%) 20 (0%) 23 (0%) 300 (6%) 405 (8%) 705 (15%) 4771
Muscle contraction 0 (0%) 0 (0%) 0 (0%) 14 (29%) 2 (4%) 16 (33%) 49
Listed in any of the above 19 29 48 453 656 1109 6574
Other 3 22 25 383 513 896 5639
Unannotated 85 48 133 127 221 348 9744
Total 107 99 206 963 1390 2353 21957
aGenes located on chromosome 12BMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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Splenocyte proliferation was determined by mitogen-
induced 3H-thymidine uptake. There was no difference in
proliferation between the two strains after ex vivo stimula-
tion with Con A (T-cell stimulus), LPS (B-cell stimulus) or
Lectin (B- and T-cell stimulus) (data not shown). We
observed no differences in the number of CD19+ (B),
CD3ε+ (T), CD4+(Th) and CD8+ (CTL) cells (data not
shown).
Finally we determined levels of IgM and subclasses of IgG
in the sera of the mock- and B. pertussis-inoculated mice
(Figure 3). Infection did not affect Ig levels compared to
mock-infected mice of the same strain. We did, however,
observe a significant difference in the Ig subset distribu-
tion between the two mouse strains (either mock- or B.
pertussis-inoculated). C3H mice had significantly higher
serum levels of IgM, IgG1, IgG2a and IgG3, while HcB-28
mice had significantly higher IgG2b levels compared to
C3H mice. Importantly, HcB-28 mice had no detectable
levels of IgG2a in the serum at all, which is consistent with
the difference in gene expression at the Igh-1  locus
between the two mouse strains.
Clinical and pathological findings in B. pertussis-infected 
C3H and HcB-28 mice
To examine whether the two mouse strains differed in
weight loss after infection, we determined their body
weights after infection. Infected mice lost three to four
percent of their body weight during the first five days post-
inoculation, while all mock-inoculated mice gained
weight during these five days (Figure 4). No significant
differences in the gain or loss of weight were observed
between the two strains, irrespective whether they were
infected or not.
As a quantitative endpoint for inflammation, we deter-
mined lung weights relative to body weight. All mock-
inoculated mice had relative lung weights of approxi-
mately one percent five days after inoculation, while B.
pertussis-infected mice had relative lung weights of up to
three percent. This difference in relative lung weights due
to B. pertussis infection is significant from day one till day
five post-inoculation, but was similar in both mouse
strains (data not shown).
Histopathological evaluation of lung sections was per-
formed as a second parameter of lung inflammation.
Intranasal inoculation of B. pertussis causes an acute
inflammatory response that is characterized by influx of
polymorphonuclear leukocytes (PMNs) and macro-
phages, starting in the perivascular and peribronchiolar
areas on day one, and extending to alveolar walls and
lumina on days three and five. No differences were
observed in the histopathological lesions findings
between the two mouse strains (Figure 5 and 6).
Table 2: Candidate susceptibility genes
Symbol Max.folda P-value Groupb Description
2610204M08Rik 1.5 0.0000000 A RIKEN cDNA 2610204M08 gene
BC022687 3.7 0.0005453 cDNA sequence BC022687
LOC544906c 2.6 0.0024627 similar to monoclonal antibody heavy chain
LOC382694c 2.8 0.0043821 similar to immunoglobulin heavy chain
LOC211331c 2.7 0.0002482 similar to Ig H-chain
LOC238440c 2.7 0.0016035 similar to IgE antibody heavy chain (VDJ)
LOC238448c 3.2 0.0000868 similar to Igh-VJ558 protein
LOC544911c 2.1 0.0000310 similar to heavy chain V region VH558 A1/A4 precursor
LOC432692 1.4 0.0005147 B LOC432692
LOC544805c 3.5 0.0000050 similar to Ig heavy chain variable region precursor
1700001K19Rik 1.6 0.0002085 RIKEN cDNA 1700001K19 gene
Amn 1.7 0.0002930 amnionless
Ppp1r13b 2.2 0.0000019 protein phosphatase 1, regulatory (inhibitor) subunit 13B
Adssl1 1.5 0.0001518 adenylosuccinate synthetase like 1
Akt1 1.8 0.0000206 thymoma viral proto-oncogene 1
AI450948 1.5 0.0048316 expressed sequence AI450948
Igh-1ac,d 3.6 0.0000000 immunoglobulin heavy chain 1a (serum IgG2a)
aMaximum fold-change between genes that are located in Bps1 and that are significantly differentially expressed between C3H and HcB-28 mice.
bHierarchical clustering as presented in figure 2, higher in C3H (A) or higher in HcB-28 (B).
cIn the most recent annotation of the murine genome, eight probes map to the Immunoglobulin heavy chain complex (Igh) similar to Ig heavy chain 
variable region precursor.
dThe oligo was designed based on accession number XM_484178 annotated as Igh-1a. Because this annotation is based on the reference C57BL/6 
mice, the oligo can be considered as Igh-1b annotated.BMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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Serum levels of immunoglobulin classes after B. pertussis infection Figure 3
Serum levels of immunoglobulin classes after B. pertussis infection. Twenty-four mice per group were inoculated with 
either B. pertussis or with culture medium only (Mock), mice were subsequently euthanized at one, three or five days post inoc-
ulation. Blood was collected for the measurement of serum levels of immunoglobulin classes. C3H mice are presented in red 
and HcB mice are presented in green. Dashed lines represent mock-inoculated mice and continuous lines represent B. pertus-
sis-inoculated mice. Error bars represent the standard deviation. No significant difference (P > 0.05, Bonferoni, ANOVA) was 
found between mock- or B. pertussis-inoculated mice of the same mouse strain, except for IgM at day 5 in C3H mice, IgG2a at 
day 5 in C3H mice, IgG2b at day 3 in HcB mice, IgG3 at day 1 in C3H mice and IgG3 at day 3 in HcB mice. All serum levels 
were significantly different (P < 0.05, Bonferoni, ANOVA) between the two strains of mice except for IgM at day 5, IgG1 at day 
1 and IgG2b at all days for B. pertussis infected HcB mice compared to C3H mice.
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Discussion
Studying genetic differences in susceptibility to B. pertussis
infection may point to novel insights in the pathogenesis
of this infection. We have previously identified B. pertussis
susceptibility locus-1 (Bps1) in HcB-28 mice [2]. The Bps1
locus is located on chromosome 12, spanning a region of
185 genes and has a dominant positive effect on the clear-
ance of B. pertussis from the lung. In this study we exam-
ined gene expression profiles in HcB-28 and C3H mice,
which differ in their susceptibility to B. pertussis. Twelve
and a half percent of the genomes of these mice are from
a different genetic background [9,10]. The traditional
approach for identification of relevant genes in suscepti-
bility loci is a combination of positional cloning and link-
age analysis [11,12]. This method has proven to be
effective [7,13], but has disadvantages. We have therefore
chosen for an alternative strategy. Using this approach we
attempted to identify candidate susceptibility genes that
control the difference between these two mouse strains.
We hypothesized that the difference in susceptibility to B.
pertussis infection could (partly) be explained by a differ-
ent gene expression profile between the mouse strains.
We have previously shown that B. pertussis infection in
C3H mice induces a wide transcriptional response, which
appears to be partly specific for B. pertussis and partly non-
specific [14]. This study revealed that 1,841 genes are dif-
ferentially expressed in the lungs of mice after B. pertussis
inoculation, and most up-regulated genes are involved in
immune- and inflammation-related processes or in
generic processes, while most down-regulated genes are
involved in non-immune processes. In the present study,
we found that HcB-28 and C3H mice showed a similar
gene expression profile upon infection and identified
approximately 650 additional genes regulated by B. per-
tussis, most of which were weakly up- or down-regulated.
However, the gene expression profiles and enrichment for
GO categories were identical as described in the previous
study. A substantial number of genes and pathways sug-
gest a central role of PMN recruitment and activation in
the pathogenesis of B. pertussis infection. The transcrip-
tional profiles further indicate in particular the signifi-
cance of TLR activation and apoptosis [14]. The reason for
the detection of the 650 additional genes, besides the
strain differences, is that by adding an extra mouse strain
the number of samples doubled increasing the power of
detection. Hundred and thirty-nine genes which we have
described previously to be regulated upon B. pertussis
infection were not detected in the present study. These
genes were borderline significantly regulated (median
FDR of 0.03) and only slightly induced (median 1.4-fold).
These genes are therefore probably less important in the
host response to B. pertussis infection. The finding that this
list of 139 genes does not show significant enrichment for
any GO-term, including immunological terms, corrobo-
rates this.
Although the two mouse strains differ in 12.5% of their
genome (12.5% of the genomes of these mice are from a
different genetic background), we observed no marked
differences in their phenotypical characteristics other than
the previously observed difference in bacterial numbers in
the lungs after infection (Figure 1b). C3H mice did have
slightly higher numbers of circulating platelets and white
blood cells compared to the HcB mice, but the cellular
proportions, as well as the proliferation of splenocytes
was identical for both strains. There was also no signifi-
cant difference observed in body weight, lung weight and
histopathological findings in response to B. pertussis infec-
tion between the two mouse strains. The major difference
is that HcB-28 mice did not have detectable IgG2a serum
levels.
We observed 206 genes that were differentially expressed
between the two mouse strains, but these genes were iden-
tically expressed in mock- or B. pertussis-inoculated mice.
The majority of these genes (65%) are unannotated. These
unannotated genes tend to have no GO functional anno-
tation, because they are not "regular" protein-coding
genes and many of them are not (sufficiently) mapped to
a chromosomal locus to warrant including them under
chromosome 12 or Bps-1. The mentioned 23 genes, which
were mapped to chromosome 12, are significant at P =
5.29e-014 (Fisher exact probability, Bonferroni correction
for multiple testing). The same test applied to all other
mouse chromosomes yielded P values > 0.05. Twenty-
three out of the 206 genes were located on chromosome
12, which can be explained by the fact that approximately
Relative gain or loss of weight after inoculation Figure 4
Relative gain or loss of weight after inoculation. 
Twenty-four mice per group were inoculated with either B. 
pertussis or culture medium only (Mock) and body weights 
were measured daily.
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one fifth of the genetic variation between the two mouse
strains is due to variation on chromosome 12 [2]. Because
the genes that were differentially regulated between the
two mouse strains only showed differences in expression
before infection, it appears likely that such intrinsic differ-
ences in gene regulation are involved in determining dif-
ferences in susceptibility to B. pertussis infection.
Alternatively, such genetic differences may be explained
by genes that are not differentially regulated between
these two strains of mice, or by processes at present not
fully characterized and possibly involving differential
expression of genes by mechanisms such as microRNA's.
Remarkably, 17 of these genes were located in the Bps1
region, 8 of which mapped to the Igh complex. Among
these 8 genes were the Igh-1 gene and genes that encode
for Ig heavy chain variable regions. We observed a signifi-
cantly higher expression (up to 2.8-fold) of the gene vari-
ant of Igh-1 isotype b in HcB mice compared to C3H mice.
The Igh locus is genetically polymorphic and very com-
plex [28]. The Igh-1 gene exists in 2 major genetic variants
(Igh-1a and Igh-1b) with 83.8% similarity [29]. The Igh-1a
allele codes for the heavy chain of IgG2a while the Igh-1b
allele codes for the heavy chain of IgG2c [30]. Mouse
strains such as C57BL/6 and C57BL/10 (the donor strain
of the HcB mice) only contain the gene variant Igh-1b and
are therefore incapable of producing IgG2a, while mouse
strains such as BALB/c only contain the gene variant of
Igh-1a  and are therefore incapable of producing IgG2c
Summary of lung pathology post mock- or B. pertussis-inoculation Figure 5
Summary of lung pathology post mock- or B. pertussis-inoculation. H&E stained slides were examined for alveolitis, 
perivasculitis and hypertrophy of mucus-producing glands. Lung lesions were scored semi-quantitatively as absent (0), minimal 
(1), slight (2), moderate (3), marked (4), or severe (5) per type of lesion and added up to calculate the pathology-score (range 
0–15). Dots represent the pathology score per individual mouse, horizontal lines represent the groups median.
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[29,30]. The oligo for Igh-1 spotted on the microarray, was
designed based on accession number XM_484178 anno-
tated as Igh-1a. Because this annotation is based on the
reference C57BL/6 mice, this oligo can be considered as
Igh-1b annotated. In the sera of HcB mice we detected no
IgG2a while C3H mice had significant titers of IgG2a,
thereby confirming the expression results. It is tempting to
speculate if and how genes within the Igh complex may
affect differences early in the course of B. pertussis infec-
tion. Possible mechanisms may include differences in
transcriptional gene regulation affecting immune respon-
siveness, different function of the IgG2a or c isotypes, or
different usage of V chains. This latter possibility might
imply the existence of "natural antibodies" reacting with
B. pertussis epitopes. It has previously been shown that
genes within the Igh-1 locus are predominantly associated
with the course of a herpes simplex virus type-1 (HSV-1)
infection in mice by an unknown mechanism [31-33].
Pro-inflammatory cytokines such as IL-1β, IL-4, IL-6 and
IL-7 participate in this infection [34]. Interestingly, natu-
ral killer cell activity appears to be regulated by the Igh-1
locus but could not simply explain the differences in HSV-
1 susceptibility [33]. Igh-linked genes have further been
implicated in T suppressor cell activity [35,36].
Conclusion
In this study we reduced the number of candidate suscep-
tibility genes within the Bps1 locus by microarray analysis.
Gene expression changes upon B. pertussis infection
appear highly identical between C3H and HcB-28 mouse
Examples of lung pathology post B. pertussis inoculation Figure 6
Examples of lung pathology post B. pertussis inoculation. Lung sections (H&E, obj x 20) from B. pertussis infected mice. 
A: HcB28 day 1, mild alveolitis (grade 2 on scale from 1–5), as seen by inflammatory cells in alveolar septa and spaces. B: C3H 
day 3, alveolitis and thickened septa (pneumonia) varying from grade 3 (upper, right) to 5 (bottom). C: C3H day 3, asterix: 
perivasculitis grade 5, and arrow: hypertrophy bronchiolar epithelium, grade 3. D: HcB28 day 3, no major differences in pathol-
ogy compared to C3H (B and C).BMC Microbiology 2007, 7:88 http://www.biomedcentral.com/1471-2180/7/88
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strains despite the different course of B. pertussis infection
in these strains. Because the genes that were differentially
regulated between the mouse strains only showed differ-
ences in expression before infection, it appears likely that
such intrinsic differences in gene regulation are involved
in determining differences in susceptibility to B. pertussis
infection. Alternatively, such genetic differences in suscep-
tibility may be explained by genes that are not differen-
tially regulated between these two mouse strains or by
processes other than differential gene expression. Genes
in the Igh complex, among which Igh-1, may be likely can-
didates to explain differences in susceptibility to B. pertus-
sis. Further work should establish the role of the Igh
complex in B. pertussis infection and determine its mode
of action.
Supplementary data
Raw data as well as the detailed description of the experi-
ment was uploaded to the freely accessible online data-
base ArrayExpress [37]. Expression levels of all 2,559
genes are presented in the additional files.
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